OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Generalised Erythema reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 5,694 reports · 119 co-occurring drugs

As of the last recalculation, Generalised Erythema appears in 5,694 FAERS reports alongside 119 co-occurring drug terms. The strongest observed disproportionality signal is IOHEXOL (PRR 16.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Iohexol3716.416.5
Propofol13714.014.1
Sevoflurane2310.210.2
Febuxostat Tablets 40 Mg269.49.4
Febuxostat Tablets 80 Mg269.49.4
Cefazolin Sodium288.58.5
Cefazolin218.48.5
Febuxostat378.18.1
Amoxicillin And Clavulanate Potassium567.67.6
Carbamazepine1347.57.5
Lamotrigine2567.47.4
Fosaprepitant Dimeglumine277.27.2
Vemurafenib216.46.4
Cefuroxime196.16.1
Colchicine425.95.9
Ibuprofen And Diphenhydramine Citrate365.75.7
Aprepitant285.65.6
Amoxicillin1145.55.6
Hydrocortisone Sodium Succinate145.55.5
Clarithromycin505.45.4
Dimethyl Fumarate1755.35.3
Dimenhydrinate155.25.2
Rifampicin145.15.1
Sorafenib264.64.6
Lithium Carbonate214.54.5
Methylprednisolone Sodium Succinate574.54.5
Desloratadine134.44.4
Valproate Sodium254.44.4
Glatiramer Acetate704.34.3
Rocuronium Bromide134.04.0
Captopril103.83.8
Rabeprazole233.83.8
Atropine83.53.5
Losartan Potassium And Hydrochlorothiazide113.53.5
Cimetidine93.43.4
Atropine Sulfate103.43.4
Lamotirigine653.33.3
Lamotrigine Extended-Release653.33.3
Lamotrigine Chewable Dispersible653.33.3
Naproxen Sodium Tablet473.33.3
Sulfamethoxazole And Trimethoprim713.13.1
Sotalol Hydrochloride143.13.1
Ketoprofen113.13.1
Fish Oil753.13.1
Bendamustine Hydrochloride103.13.1
Vancomycin462.92.9
Dexamethasone Sodium Phosphate82.92.9
Vancomycin Hydrochloride512.82.8
Niacin92.82.8
Panitumumab122.82.8
Levofloxacin462.82.8
Levofloxacin In 5% Dextrose462.82.8
Epoprostenol102.82.8
Metformin Hcl422.82.8
Phenobarbital112.82.8
Levocetirizine Dihydrochloride182.72.7
Valsartan And Hydrochlorothiazide102.72.7
Rabeprazole Sodium202.72.7
Diclofenac Sodium1092.72.7
Darunavir112.72.7
Raltegravir122.72.7
Olmesartan Medoxomil262.72.7
Amlodipine Besylate And Valsartan82.62.6
Piperacillin Sodium And Tazobactam Sodium142.62.6
Midazolam Hydrochloride192.62.6
Prasugrel Hydrochloride72.52.5
Pitavastatin Calcium72.52.5
Sulfasalazine532.52.5
Midazolam172.52.5
Cetuximab212.52.5
Granisetron72.42.4
Fexofenadine112.42.4
Nevirapine62.42.4
Eszopiclone162.32.3
Isoniazid102.32.3
Oxcarbazepine202.32.3
Olanzapine Pamoate252.22.2
Zonisamide92.22.2
Ceftriaxone Sodium222.12.1
Granisetron Hydrochloride62.12.1
Interferon Beta-1B112.12.1
Oseltamivir Phosphate142.12.1
Deferasirox152.12.1
Ibuprofen Tablets, Coated242.12.1
Ibuprofen Sodium242.12.1
Methoxy Polyethylene Glycol-Epoetin Beta62.02.0
Pyrazinamide51.91.9
Oxaliplatin381.91.9
Dexlansoprazole211.81.8
Fentanyl Citrate91.81.8
Ribavirin321.81.8
Brentuximab Vedotin51.81.8
Rotigotine71.81.8
Rivastigmine91.71.7
Tenofovir Disoproxil Fumarate Tablets41.71.7
Certolizumab Pegol531.71.7
Golimumab381.61.6
Daptomycin41.61.6
Thiotepa41.51.5
Peginterferon Alfa-2A221.51.5
Paclitaxel (Aibumin-Bound)331.51.5
Peginterferon Beta-1A51.41.4
Exenatide201.41.4
Loratadine And Pseudoephedrine Sulfate31.41.4
Ustekinumab381.41.4
Diclofenac Potassium41.41.4
Pemetrexed Disodium141.31.3
Diclofenac Potassium, Film Coated31.31.3
Diclofenac Potassium Tablets31.31.3
Fremanezumab-Vfrm41.31.3
Teriparatide381.21.2
Gefitinib31.21.2
Etanercept1931.21.2
Dalfampridine231.21.2
Suvorexant41.11.1
Enzalutamide171.11.1
Palivizumab41.01.0
Apremilast380.90.9
Alirocumab60.90.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.